or Try an Advanced Search...

    Technical Analysis for XERS - Xeris Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 1.85 -1.60% -0.03
    XERS closed down 1.6 percent on Wednesday, May 8, 2024, on 59 percent of normal volume.
    Earnings due: May 9
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical XERS trend table...
    Date Alert Name Type % Chg
    20 DMA Support Bullish 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Bollinger Band Squeeze Range Contraction -1.60%
    BB Squeeze Started Range Contraction -1.60%
    Death Cross Bearish -2.37%
    Pocket Pivot Bullish Swing Setup -2.37%
    Gapped Up Strength -2.37%
    Up 3 Days in a Row Strength -2.37%
    New Uptrend Bullish -2.12%
    Gapped Up Strength -2.12%
    Older End-of-Day Signals for XERS ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 14 hours ago
    20 DMA Support about 19 hours ago
    Down 3% about 19 hours ago
    Fell Below Previous Day's Low about 19 hours ago
    Down 2 % about 19 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    XERS Chart by TradingView
    Basic chart:

    Profile

    Xeris Pharmaceuticals Inc is a specialty pharmaceutical company leveraging its novel non-aqueous formulation technology platforms, XeriSol and XeriJect, to develop and commercialize ready-to-use injectable and infusible drug formulations.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Health Sciences Natural Sciences Pharmacy Pharmaceutical Sciences Pharmaceutics

    Is XERS a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Xeris Pharmaceuticals Q1 2024 Earnings Preview
    May 6 Xeris Enters Into an Exclusive Worldwide Collaboration and License Agreement With Beta Bionics
    May 2 Pleasing Signs As A Number Of Insiders Buy Xeris Biopharma Holdings Stock
    May 2 Xeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024
    Apr 17 Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
    Apr 5 Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) top owners are retail investors with 51% stake, while 45% is held by institutions
    Apr 2 Xeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare Conference
    Mar 30 Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
    Mar 28 Xeris gains as Oppenheimer highlights drug technology
    Mar 9 Here's What Analysts Are Forecasting For Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) After Its Annual Results
    See more XERS news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.26
    52 Week Low 1.46
    Average Volume 1,709,478
    200-Day Moving Average 2.17
    50-Day Moving Average 2.11
    20-Day Moving Average 1.81
    10-Day Moving Average 1.81
    Average True Range 0.10
    RSI (14) 43.82
    ADX 21.47
    +DI 20.13
    -DI 22.33
    Chandelier Exit (Long, 3 ATRs) 1.77
    Chandelier Exit (Short, 3 ATRs) 1.99
    Upper Bollinger Bands 1.97
    Lower Bollinger Band 1.66
    Percent B (%b) 0.62
    BandWidth 17.21
    MACD Line -0.07
    MACD Signal Line -0.10
    MACD Histogram 0.0354
    Fundamentals Value
    Market Cap 255.53 Million
    Num Shares 138 Million
    EPS -0.46
    Price-to-Earnings (P/E) Ratio -4.02
    Price-to-Sales 2.60
    Price-to-Book 102.57
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.97
    Resistance 3 (R3) 1.97 1.92 1.95
    Resistance 2 (R2) 1.92 1.89 1.93 1.94
    Resistance 1 (R1) 1.89 1.87 1.87 1.89 1.94
    Pivot Point 1.84 1.84 1.83 1.85 1.84
    Support 1 (S1) 1.81 1.81 1.79 1.81 1.76
    Support 2 (S2) 1.76 1.79 1.77 1.76
    Support 3 (S3) 1.73 1.76 1.75
    Support 4 (S4) 1.73